The head and neck cancer immune landscape and its immunotherapeutic implications.
about
The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.Head and neck cancer: improving outcomes with a multidisciplinary approach.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaComplement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function.Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation OncoloNatural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.Leveraging Genomics for Head and Neck Cancer Treatment.Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.Checkpoint immunotherapy in head and neck cancers.T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications.Immunotherapy for Head and Neck Squamous Cell Carcinoma.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report.Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer.Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapyOn the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor AntibodiesPD-L1 blockade enhances anti-tumor efficacy of NK cellsMetformin Clinical Trial in HPV+ and HPV- Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune InfiltrateImmune Checkpoint Inhibition in Head and Neck Cancer
P2860
Q37710125-8F11B792-9F88-4BFA-BDBA-37B45C6903A9Q37743484-AC2375F4-805E-4068-A318-9F7531FCF761Q41522410-6520DAB2-8A73-45ED-AB34-30D0F091B3D0Q46540302-63D08116-F80F-4DDE-A863-BAB638DB4D1EQ47120622-8FAA2BA1-828B-4716-B976-BE0FCDE3B8DBQ47299395-BF07277D-5C3F-426E-A29F-D30DE7F1C318Q49351739-961693E0-7F05-4905-9489-1B909920618CQ50116331-A76697AB-3D03-4A00-AAA1-E06114E26FF7Q50545420-ECE6A96C-7071-4F2A-A98D-478EF602F8E5Q52679182-615C4AB3-AE5D-466D-824D-4C93CB18B6C6Q52796907-5572395D-745C-4362-92E0-52E5E0E5397FQ53098427-BC4B53E6-43C2-4E01-A163-E49EFEE6C30AQ53109856-A26C7FC2-10A5-4718-8FD4-BDB31D6C706EQ53359622-DEAF3CA8-4F4D-4CFA-A397-8870F5F92B4AQ53704789-407FCADC-F21E-4E05-B752-3D39BD79CCC7Q55003290-EA2EE513-89D8-4EDB-B2FC-CDD018BCABA8Q55092262-6028AEE3-490F-47BD-9694-C28460A919A3Q55279175-FFBED791-48D0-4390-B7D3-6A301667C4A6Q57138281-97282601-5AB8-46C5-A9BF-E5CE31AA862DQ57492388-9ADC5817-CB6B-4565-B969-240902CCA0AEQ58129516-72EFDDE7-D11B-4B6B-9124-79B1107D900CQ58573253-97BC2854-8A44-4945-825D-B8F8D5CACEF5Q58694216-EFD0AA71-8A2F-44E7-AFFC-9BF44DE6D13A
P2860
The head and neck cancer immune landscape and its immunotherapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The head and neck cancer immune landscape and its immunotherapeutic implications.
@en
The head and neck cancer immune landscape and its immunotherapeutic implications.
@nl
type
label
The head and neck cancer immune landscape and its immunotherapeutic implications.
@en
The head and neck cancer immune landscape and its immunotherapeutic implications.
@nl
prefLabel
The head and neck cancer immune landscape and its immunotherapeutic implications.
@en
The head and neck cancer immune landscape and its immunotherapeutic implications.
@nl
P2093
P2860
P1433
P1476
The head and neck cancer immune landscape and its immunotherapeutic implications.
@en
P2093
A Ari Hakimi
Alexis Desrichard
Ken-Wing Lee
Luc Gt Morris
Nadeem Riaz
Rajarsi Mandal
Timothy A Chan
Yasin Şenbabaoğlu
P2860
P304
P356
10.1172/JCI.INSIGHT.89829
P577
2016-10-20T00:00:00Z